Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063899
Chunk: 180

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 180
---
 million in prior year, which there are no such gain in current year.

Net loss attributable to the Company

For the years ended December
31, 2024, and 2023, net loss attributable to the Company (excluding net loss attributable to non-controlling interests) was $4,267,806
and $2,824,647, respectively.

Results of Operations for the Years ended December 31, 2023, and 2022

During the second quarter
of 2023, the Company made a decision to streamline its operations by terminating clinic services and suspending non-lead R&D projects.
This measure is aimed at optimizing the allocation of our resources and focusing our efforts on advancing our lead projects, which hold
the most promise for commercial success and beneficial impact. This decision aligns with our commitment to enhance shareholder value and
effectively drive our core objectives forward in the competitive landscape.

<div align='center'>88</div>

The following table summarizes
our results of operations for the years ended December 31, 2023, and 2022.

|                                                                          |     |   |   Year Ended 
 December 31, 
         2023 |   |     |   |   Year Ended 
 December 31, 
         2022 |   |
|:-------------------------------------------------------------------------|:----|:--|-------------:|:--|:----|:--|-------------:|:--|
| Revenue                                                                  |     |   |              |   |     |   |              |   |
| Healthcare services income                                               |     | $ |      431,378 |   |     | $ |    1,295,889 |   |
| Operating expenses                                                       |     |   |              |   |     |   |              |   |
| Cost of healthcare services                                              |     |   |     (420,812 | ) |     |   |   (1,215,824 | ) |
| Research and development expenses                                        |     |   |   (5,198,329 | ) |     |   |   (9,219,595 | ) |
| General and administrative fees                                          |     |   |   (1,930,637 | ) |     |   |   (5,220,405 | ) |
| Legal and professional fees                                              |     |   |   (2,538,161 | ) |     |   |   (2,888,140 | ) |
| Other operating expenses                                                 |     |